Trovafloxacin mesylate

Pricing Availability   Qty
Description: Antibiotic; inhibits bacterial DNA synthesis
Alternative Names: CP 99219
Chemical Name: 7-[(1α,5α,6α)-6-Amino-3-azabicyclo[3.1.0]hex-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid mesylate
Purity: ≥99% (HPLC)
Datasheet
Citations
Reviews (1)
Literature (2)

Biological Activity for Trovafloxacin mesylate

Trovafloxacin mesylate is a fluoroquinolone antibiotic. Inhibits bacterial DNA topoisomerase IV and DNA gyrase and forms a stable quinolone-DNA complex with these enzymes which reversibly inhibits DNA synthesis. Displays potent activity against gram-positive and gram-negative bacteria. Increases the production of mitochondrial NO in immortalized hepatocytes; also increases mitochondrial Ca2+. Inhibits Panx-1 (IC50 ~ 4μM).

Licensing Information

Sold for research purposes under agreement from Pfizer Inc.

Compound Libraries for Trovafloxacin mesylate

Trovafloxacin mesylate is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen FDA-Approved Drugs. Find out more about compound libraries available from Tocris.

Technical Data for Trovafloxacin mesylate

M. Wt 512.46
Formula C20H15F3N4O3.CH3SO3H
Storage Desiccate at RT
Purity ≥99% (HPLC)
CAS Number 147059-75-4
PubChem ID 62960
InChI Key DYNZICQDCVYXFW-GIPYJWDTSA-N
Smiles O=C2C1=CC(F)=C(N4C[C@@]([C@H]5N)([H])[C@@]5([H])C4)N=C1N(C3=C(F)C=C(F)C=C3)C=C2C(O)=O.CS(=O)(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Trovafloxacin mesylate

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
water 25.62 50
DMSO 51.25 100

Preparing Stock Solutions for Trovafloxacin mesylate

The following data is based on the product molecular weight 512.46. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.95 mL 9.76 mL 19.51 mL
5 mM 0.39 mL 1.95 mL 3.9 mL
10 mM 0.2 mL 0.98 mL 1.95 mL
50 mM 0.04 mL 0.2 mL 0.39 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for Trovafloxacin mesylate

References for Trovafloxacin mesylate

References are publications that support the biological activity of the product.

Neu and Chin (1994) In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob.Agents Chemother. 38 2615 PMID: 7872757

Gootz et al (1996) Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Antimicrob.Agents Chemother. 40 2691 PMID: 9124824

Poon et al (2014) Unexpected link between an antibiotic, pannexin channels and apoptosis. Nature 507 329 PMID: 24646995


If you know of a relevant reference for Trovafloxacin mesylate, please let us know.

View Related Products by Product Action

View all DNA, RNA and Protein Synthesis Inhibitors

Keywords: Trovafloxacin mesylate, Trovafloxacin mesylate supplier, CP99219, antibiotics, antibacterial, antimicrobial, DNA, topoisomerase, IV, gyrase, dna, synthesis, inhibitors, inhibits, Pfizer, CP, 99219, DNA,, RNA, and, Protein, Synthesis, Antibiotics, Topoisomerase, Gap, Channels, 3863, Tocris Bioscience

Citations for Trovafloxacin mesylate

Citations are publications that use Tocris products.

Currently there are no citations for Trovafloxacin mesylate. Do you know of a great paper that uses Trovafloxacin mesylate from Tocris? Please let us know.

Reviews for Trovafloxacin mesylate

Average Rating: 5 (Based on 1 Review.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Trovafloxacin mesylate?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Hepatoxic side effects of Trovafloxacin was studied against other several quinolones.
By Anonymous on 12/15/2019
Species: Human

Hepatoxic side effects of Trovafloxacin was studied against other several quinolones (temafloxacin, sparfloxacin, grepafloxacin, trovafloxacin) which have been withdrawn or their use severely limited soon after their clinical introduction owing to severe and sometimes life-threatening adverse events.

review image

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Cell Cycle and DNA Damage Research Product Guide

Cell Cycle and DNA Damage Research Product Guide

This product guide provides a review of the cell cycle and DNA damage research area and lists over 150 products, including research tools for:

  • Cell Cycle and Mitosis
  • DNA Damage Repair
  • Targeted Protein Degradation
  • Ubiquitin Proteasome Pathway
  • Chemotherapy Targets
Huntington's Disease Research Product Guide

Huntington's Disease Research Product Guide

This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:

  • Somatic Instability
  • Proteolysis and Inclusion Bodies
  • Transcriptional Dysregulation
  • Mitochondrial Dysfunction
  • Nuclear-Cytoplasmic Transport Interference
  • Excitotoxicity
  • Stem Cells